Background_microfluidics_edited_edited_e

Welcome to Dermagnostix!

At Dermagnostix, we envision the next level for molecular diagnostics in human skin to improve patients’ lives and clinical practice in dermatology.

1/1

Why Dermatology?

Dermatologic diseases are the 4th most common cause of all human illnesses.

Every individual experiences a skin disease at least once during their lifetime.

7 of the 15 best selling drugs are already being used in dermatology today and many more promising treatments are in the pipeline.

Conventional Diagnostics

based on clinical view and histopathology are imprecise and impede the optimal use of the already available highly specific modern therapies in dermatology.

The Solution

is to offer modern diagnostics for modern therapies. With our first test – PsorEx – to differentiate between eczema and psoriasis on molecular level we achieved a milestone for molecular diagnostics in dermatology.

Find out more about our pipeline products

Dermagnostix offers

a comprehensive technological platform for fast and objective molecular diagnostics in dermatology to reduce health care costs and improve patient treatment.

Find out more about our technology

Dermagnostix provides molecular diagnostic solution for dermatology.

economic

fast

easy

precise

The Dermagnostix-Team

Dermagnostix is a spin-off from the Hahn-Schickard Institut in Freiburg, the Helmholtz Zentrum München (HMGU) and TU München. We are located in Southern Germany (Baden-Wuerttemberg and Bavaria).
Our multidisciplinary team unites expertise in dermatology, basic research, microfluidics and artificial intelligence to bring the most innovative products to market.